top of page

PUBLICATIONS AND CONFERENCE REPORTS

Publications

  1. Binsker, U., Jäckel, C., Rau, J., Borowiak, M., Salzinger, C., Garcia-Menino, I., Käsbohrer, A. & Hammerl, J.A. (P5) (2024) Klebsiella pneumoniae arms itself: Poultry food chain drives spread and evolution of mcr-1.26-IncX4 plasmids. Microbiology Spectrum (Research MS, IF 3.43), 12(6), e0421023 (Epub. 01. May 2024). https://10.1128/spectrum.04210-23

  2. Silva-Bea, S., García-Meniño, I., Rey, S., Romero, M., Fernández, J., Hammerl, J.A. (P5), Mora, A. & Otero, A. (2024) Draft genome sequence of Klebsiella pneumoniae strain KP33, a convergent hyper-biofilm forming MDR strain belonging to the emerging ST16 lineage that harbors multiple hypervirulence genes. Microbial Resource Announcements (Research MS), 13(4), e01192-23 (Epub. 07. Feb. 2024). https://doi.org/10.1128/mra.01192-23

  3. Kürekci, C., Ünaldı, O., Åžahin, S., Garcia-Menino, I. & Hammerl, J.A. (P5) (2023) Genome sequencing of ESBL-producing Klebsiella pneumoniae isolated from local raw chicken meat samples in Türkiye. Antibiotics (Research MS, IF 4.80), 13(1), 14 (Epub. 21. Dec. 2023). https://doi.org/10.3390/antibiotics13010014

  4. Jakob N, Hammerl JA (P5), Swierczewski BE, Würstle S, Bugert JJ (P4) (2024) Appelmans Protocol for in vitro Klebsiella pneumoniae phage host range expansion leads to induction of a novel temperate linear plasmid prophage vB_KpnS-KpLi5.

 

Oral presentations

  1. Drulis-Kawa Z. (P1) The evolutionary trade-offs in phage-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa 5th International hands-on Phage Biotechnology course, 19th-23rd, June 2023, Braga, Portugal, https://www.ceb.uminho.pt/bbig/HOP2023/Program.html

  2. Drulis-Kawa Z. (P1)  Biofilm-infecting phages” ESCMID Postgraduate Technical Workshop, Personalised phage therapy: from the lab to the patient, 25th-27th July 2023, Brussels, Belgium, https://www.escmid.org/profession-career/educational-activities/2023-escmid-courses-and-workshops/escmid-onsite-courses-and-workshops

  3. Drulis-Kawa Z. (P1) K-sensitization strategy to improve existing treatment protocols for effective therapy against AMR K. pneumoniae. Medical Biodefense Conference 2023, 22nd – 25th October 2023, Munich, Germany, https://conference.instmikrobiobw.de/wp-content/uploads/2023/10/MBDC2023_Final_Program_web.pdf

  4. Drulis-Kawa Z. (P1). & Dorotkeiwicz-Jach A. The new Community of Practise CoP entitled (ACOH- Arqus Community for One Health)  2024 Arqus Annual Conference, University of Minho, 2nd - 4th July – satellite sessions Laboratory of Applied Health, Microbiology, Universidade do Minho, Campus de Gualtar, 4710-057 Braga

  5. Drulis-Kawa Z. (P1) Ewolucyjne kompromisy przy nabywaniu opornoÅ›ci na fagi przez Klebsiella pneumoniae i Pseudomonas aeruginosa” II Sympozjum Bakteriofagowe, 7th-9th September 2023, Gdansk, Poland, https://bakteriofagi.com/

  6. Drulis-Kawa Z. (P1) Acquisition of phage resistance by Klebsiella pneumoniae and Pseudomonas aeruginosa - and interactions with the immune system. XVIII Kongresu Polskiego Towarzystwa Immunologii Doświadczalnej i Klinicznej, 16-18 May 2024, Bialystok, Poland, https://immunologia2024.pl/dokumenty/18KPTIDiK-Program_ad.pdf

  7. Hazan R. (P6) Phage Banking. ESCMID Postgraduate Technical Workshop, Personalised phage therapy: from the lab to the patient, 25th-27th July 2023, Brussels, Belgium,  https://www.escmid.org/profession-career/educational-activities/2023-escmid-courses-and-workshops/escmid-onsite-courses-and-workshops

  8. Hazan R. (P6) Phage diagnostics – an overview. ESCMID Postgraduate Technical Workshop, Personalised phage therapy: from the lab to the patient, 25th-27th July 2023, Brussels, Belgium, https://www.escmid.org/profession-career/educational-activities/2023-escmid-courses-and-workshops/escmid-onsite-courses-and-workshops

  9. Vogele K (P7) – Invitris, Munich Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria New Concepts in Prokaryotic Virus-host Interactions – From Single Cells to Microbial Communities” (SPP 2330), 2nd-4th October, 2023, Berlin Germany, https://spp2330.de/

  10. Vogele K (P7), Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria. Medical Biodefense Conference 2023, 22nd – 25th October 2023, Munich, Germany, https://conference.instmikrobiobw.de/wp-content/uploads/2023/10/MBDC2023_Final_Program_web.pdf

  11. Hammerl, J.A (P5). Phagenforschung am BfR: Im Fokus des Verbraucherschutzes & der Lebensmittelsicherheit: Moderne Aspekte der Suszeptibilitätsmessung (Ramanspektroskopie, Biotraping). Phage-One Meeting - Bedeutung, Perspektive, Empfehlungen aus Sicht von Investoren – Treffen mit Investoren des AMR Action Funds und Boehringer Ingelheim. 24, May 2024, Berlin, Deutschland.

  12. Hammerl, J.A (P5). Vorkommen, Bedeutung und Einsatzmöglichkeiten von Bakteriophagen zur Biokontrolle. Nationale Referenz-, Konsiliar- und Speziallabore – Forschung und Diagnostik in der mikrobiologischen Lebensmittelsicherheit - NRL Autumn School 2024, 08.–09. October 2024, Berlin, Deutschland (online).

  13. Hammerl, J.A (P5). Bacteriophages and their potential for biocontrol in food: Fact or fiction? 2024 EFFoST / IFT-NPD Workshop on Nonthermal Processing of Foods, 07.-09. October 2024, Potsdam, Germany.

  14. Tournebize, R (P3) Des virus tueurs de bactéries pour lutter contre la résistance aux antibiotiques ?, Université Populaire du Sud Ardèche, 08/04/2024, Aubenas, France (dissemination to the general public)

  15. Wurstle S Freiburger Hygiene- and Infectiology Congress October 10, 2024

  16. Wurstle S Dietary and therapeutic Microbiome Modulation – State of the Art and Perspectives, Nov 13, 2024

  17. Wurstle S Clinical application of phage therapy, University Clinic Thüringen, Nov 20, 2024

 

 

Posters

  1. Binsker, U., Oelgeschläger, K., Käsbohrer, A. & Hammerl, J.A. (P5) (2023) Indications of transmission of mcr-1.26 IncX4 plasmids along the poultry food chain to humans. 9th Symposium on Antimicrobial Resistance in Animals and the Environment, 03.-05. Jul., Tours, France.

  2. Garcia-Menino, I., Savin, M., Jäckel, C. & Hammerl, J.A. (P5) (2023) The enemy of my enemy is my friend! MDR bacteria and their natural enemies in process-/ wastewater from livestock slaughterhouses. One Health Aotearoa Conference 2023, 05.-06. Dec., Wellington, New Zealand.

  3. Jakob, N.A.1, Hammerl, J.A. (P5), Filippov, A.A., Swierczewski, B.E., Ellison, D.W., Wölfel, R. & Bugert, J.J. (P4) (2023) Modified Appelmans protocol for in vitro Klebsiella pneumoniae phage host range expansion leads to induction of a novel temperate linear plasmid prophage vB_tLPPP-KpLi5. Medical Biodefense Conference 2023, 22.-25. Oct., Munich, Germany.

  4. Stender, J.1, Würstle, S., Vogele, K., Friese, D., Hammerl, J.A.  (P5), Wölfel, R. & Bugert, J.J. (P4) (2023) Preparing phage for therapy in infections with multidrug-resistant Klebsiella pneumoniae: The IMB protocol. Medical Biodefense Conference 2023, 22.-25. Oct., Munich, Germany.

  5. Jäckel, C., Schmoger, S., Gadicherla, A., & Hammerl, J.A.  (P5) (2023) Klebsiella-specific phages from fecal samples of animals and their suitability for therapeutic application. Medical Biodefense Conference 2023, 22.-25. Oct., Munich, Germany.

  6. Jäckel, C., Garcia-Menino, I., Schmoger, S., Gardicherla, A. & Hammerl, J.A.  (P5) (2023) Lytic Klebsiella pneumoniae phages from fecal samples and their suitability for treatment purposes. DVG: 63. Arbeitstagung des Arbeitsgebietes Lebensmittelsicherheit und Verbraucherschutz, 26.-29. Sep., Garmisch-Partenkirchen, Deutschland.

  7. Majkowska-Skrobek G, Pozniak M, Sosnowska E, Drulis-Kawa Z. (P1) (2024). Myoviruses generally select resistant klebsiella pneumoniae mutants with retained virulence features. Viruses of Microbes, 15-19, July, 2024, Cairns, Australia

  8. Olszak T, Majkowska-Skrobek G, Majewska J, Lavigne R (P2), Tournebize R (P3), Bugert JJ (P4), Hammerl JA (P5), Hazan R (P6), Vogele K (P7) & Drulis-Kawa Z. (P1) on behalf of JPIAMR KLEOPATRA Consortium. Design and implementation of effective combination of phages and antibiotics for improved therapy protocols against Klebsiella pneumoniae – JPIAMR KLEOPATRA project. Klebsiella Epidemiology and Biology Symposium 2024, 20th-22nd, November, 2024, Institut Pasteur, Paris, France

  9. Yerushalmy O, Lipszyc RR, Attiyeh A, Abid A, Vorzhev S, Heilbron SM, Tehemer A, Rokney A, Baum M, Maciejewska M, Drulis-Kawa Z (P1), Coppenhagen-Glazer S, Nir-Paz R, and Hazan R. (P6). Isolation and Characterization of 76 Phages Targeting clinical Klebsiella Strains. Klebsiella Epidemiology and Biology Symposium 2024, 20th-22nd, November, 2024, Institut Pasteur, Paris, France

  10. Fontaine V, Gedeon J, Silmane MS, Lannoy V, Osbelt L, Otwinowska A, Majkowska-Skrobek G, Wurtzer S, Moulin L, Aubry A, Bleibtreu A, Calin R, Strowig T, Drulis-Kawa Z (P1), Eckert C, Tournebize R (P3). Isolation and characterisation of bacteriophages targeting Klebsiella pneumoniae. Klebsiella Epidemiology and Biology Symposium 2024, 20th-22nd, November, 2024, Institut Pasteur, Paris, France

  11. Lood C, Garcia Menino I, Olszak T, Drulis-Kawa Z (P1), Brettraeger M, Bugert JJ (P4), Lavigne R (P2), the Kleopatra consortium and Hammerl JA (P5). Evaluating the therapeutic potential of phages and phage-derived enzymes by understanding the ‘One Health’ population structure of the 'Kleopatra’ Klebsiella collection. Klebsiella Epidemiology and Biology Symposium 2024, 20th-22nd, November, 2024, Institut Pasteur, Paris, France

  12. Stender J, Georgi M, Kachel L, Sabo M, Brückner C, Friese D, Braun S, Wölfel R, Bugert JJ (P4). Therapeutische Bakteriophagen im Galleria mellonella Infektionsmodell. 55th congress of the German Society for Military Medicine and Military Pharmacy (DGWMP), 14th- 16th November, Augsburg, Germany

bottom of page